Beam Therapeutics Inc. (BEAM) Return on equity 2020–2025
Beam Therapeutics Inc. (BEAM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.5%FY2025 · since FY2020: -79.2% → -6.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.5% | +44.9 pp |
| FY2024 | -51.4% | -37.9 pp |
| FY2023 | -13.5% | +25.9 pp |
| FY2022 | -39.4% | +5.4 pp |
| FY2021 | -44.8% | +34.4 pp |
| FY2020 | -79.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice